Proteomic analysis of spinal cord of presymptomatic amyotrophic lateral sclerosis G93A SOD1 mouse

被引:60
|
作者
Massignan, Tania
Casoni, Filippo
Basso, Manuela
Stefanazzi, Paola
Biasini, Emiliano
Tortarolo, Massimo
Salmona, Mario
Gianazza, Elisabetta
Bendotti, Caterina
Bonetto, Valentina [1 ]
机构
[1] Dulbecco Telethon Inst, Milan, Italy
[2] Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy
[3] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO USA
[4] Univ Milan, Dept Pharmacol Sci, Milan, Italy
关键词
amyotrophic lateral sclerosis; transgenic mice; superoxide dismutase 1; proteomics; two-dimensional gel electrophoresis; cyclophilin A; acetylation; phosphorylation;
D O I
10.1016/j.bbrc.2006.12.075
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease, whose primary mechanisms or causes are still not defined and for which no effective treatment is available. We have recently reported that before disease onset the level of tyrosine nitrated proteins is increased in the G93A SOD1 transgenic mouse model of ALS. In the present investigation, we carried out a protcomic analysis of spinal cord extracts from G93A SOD1 mice at the presymptomatic stage of the disease to further unravel primary events in the pathogenesis and tentatively screen for potential pharmacological targets. Using a robust two-dimensional get electrophoresis-based proteomic approach, we detected a number of proteins differentially represented in presymptomatic mice in comparison with controls. Alterations of these proteins correlate with mitochondrial dysfunction, aggregation, and stress response. Moreover, we found a variation in the isoform pattern of cyclophilin A, a molecular chaperone that protects cells from the oxidative stress. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:719 / 725
页数:7
相关论文
共 50 条
  • [1] Proteomic analysis in the SOD-1 G93A mouse model of human amyotrophic lateral sclerosis
    Scott, RL
    Cheung, NS
    Beart, PM
    Cheema, SS
    JOURNAL OF NEUROCHEMISTRY, 2001, 78 : 130 - 130
  • [2] Comparing therapeutic modulators of the SOD1 G93A Amyotrophic Lateral Sclerosis mouse pathophysiology
    Lee, Albert J. B.
    Kittel, Tyler E. E.
    Kim, Renaid B. B.
    Bach, Thao-Nguyen
    Zhang, Tian
    Mitchell, Cassie S. S.
    FRONTIERS IN NEUROSCIENCE, 2023, 16
  • [3] Spinal motoneurones are intrinsically more responsive in the adult G93A SOD1 mouse model of amyotrophic lateral sclerosis
    Jensen, Dennis B.
    Kadlecova, Marion
    Allodi, Ilary
    Meehan, Claire F.
    JOURNAL OF PHYSIOLOGY-LONDON, 2020, 598 (19): : 4385 - 4403
  • [4] Lack of Effect of Methylene Blue in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis
    Lougheed, Rosamond
    Turnbull, John
    PLOS ONE, 2011, 6 (10):
  • [5] Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1(G93A) mice
    Scaricamazza, Silvia
    Salvatori, Illari
    Amadio, Susanna
    Nesci, Valentina
    Torcinaro, Alessio
    Giacovazzo, Giacomo
    Primiano, Aniello
    Gloriani, Michela
    Candelise, Niccolo
    Pieroni, Luisa
    Loeffler, Jean-Philippe
    Rene, Frederique
    Quessada, Cyril
    Tefera, Tesfaye W.
    Wang, Hao
    Steyn, Frederik J.
    Ngo, Shyuan T.
    Dobrowolny, Gabriella
    Lepore, Elisa
    Urbani, Andrea
    Musaro, Antonio
    Volonte, Cinzia
    Ferraro, Elisabetta
    Coccurello, Roberto
    Valle, Cristiana
    Ferri, Alberto
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (08) : 1732 - 1752
  • [6] The SOD1 transgene in the G93A mouse model of amyotrophic lateral sclerosis lies on distal mouse chromosome 12
    Achilli, F
    Boyle, S
    Kieran, D
    Chia, R
    Hafezparast, M
    Martin, JE
    Schiavo, G
    Greensmith, L
    Bickmore, W
    Fisher, EMC
    AMYOTROPHIC LATERAL SCLEROSIS, 2005, 6 (02): : 111 - 114
  • [7] GPNMB RESISTS SKELETAL MUSCLE LESION IN THE SOD1 (G93A) MOUSE MODEL OF AMYOTROPHIC LATERAL SCLEROSIS
    Nagahara, Y.
    Tanaka, H.
    Tsuruma, K.
    Ono, Y.
    Noda, Y.
    Nikawa, T.
    Shimazawa, M.
    Hara, H.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 195 - 195
  • [8] G93A SOD1 alters cell cycle in a cellular model of Amyotrophic Lateral Sclerosis
    Cova, Emanuela
    Ghiroldi, Andrea
    Guareschi, Stefania
    Mazzini, Giuliano
    Gagliardi, Stella
    Davin, Annalisa
    Bianchi, Marika
    Ceroni, Mauro
    Cereda, Cristina
    CELLULAR SIGNALLING, 2010, 22 (10) : 1477 - 1484
  • [9] The effect of leukaemia inhibitory factor on SOD1 G93A murine amyotrophic lateral sclerosis
    Feeney, SJ
    Austin, L
    Bennett, TM
    Kurek, JB
    Jean-Francois, MJB
    Muldoon, C
    Byrne, E
    CYTOKINE, 2003, 23 (4-5) : 108 - 118
  • [10] The human G93A SOD1 phenotype closely resembles sporadic amyotrophic lateral sclerosis
    Synofzik, Matthis
    Fernandez-Santiago, Ruben
    Maetzler, Walter
    Schoels, Ludger
    Andersen, Peter M.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (07): : 764 - 767